1166P Tisotumab vedotin plus carboplatin or pembrolizumab in recurrent or metastatic cervical cancer: 5-year results from the innovaTV 205/GOG-3024/ENGOT-cx8 study

Journal article

Peer reviewed

B.J. Monk, E. Van Nieuwenhuysen, J. Tromp, D. Lorusso, R.E. O'Cearbhaill, S. Banerjee, D.C. Collins, M. Zikan, A.L. Jackson, K. Madsen, …

Annals of oncology, Vol.36, pp.S769-S770

09/2025

Metrics

1 Record Views

Title: 1166P Tisotumab vedotin plus carboplatin or pembrolizumab in recurrent or metastatic cervical cancer: 5-year results from the innovaTV 205/GOG-3024/ENGOT-cx8 study
Creators: B.J. Monk
E. Van Nieuwenhuysen
J. Tromp
D. Lorusso
R.E. O'Cearbhaill
S. Banerjee
D.C. Collins
M. Zikan
A.L. Jackson
K. Madsen
C. Gennigens
P.B. Ottevanger
S. Ghamande
V. Salutari
J-F. Baurain
A. Reyners
U. Conte
K. Windfeld
H. Hansen
I. Vergote
Publication Details: Annals of oncology, Vol.36, pp.S769-S770
Identifiers: 991006235738202656
Academic Unit: Obstetrics & Gynecology
Language: English
Resource Type: Journal article